Protagonist Therapeutics Insider Sold Shares Worth $18,240,568, According to a Recent SEC Filing
MT newswire2026/09/11 07:23Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
03:23 AM EDT, 09/11/2026 (MT Newswires) -- Dinesh V Patel, Director, President and Chief Executive Officer, on September 08, 2026, sold 125,000 shares in Protagonist Therapeutics (PTGX) for $18,240,568. Following the Form 4 filing with the SEC, Patel has control over a total of 522,968 common shares of the company, with 522,968 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1377121/000110465926106831/xslF345X05/tm2625158-1_4seq1.xml
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Kaldvík wins approval for 10,000-tonne salmon farming licences in Seyðisfjörður, Iceland
Reuters•2026/09/11 11:48
First Berlin reiterates Buy on Cantourage, keeps € 11 price target
Reuters•2026/09/11 11:48
Indexo shareholders vote on nominal share value cut at Oct. 1 EGM
Reuters•2026/09/11 11:46
